Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
Adoptive immunotherapy, notably involving chimeric antigen receptor (CAR)-T cells, has obtained Food and Drug Administration (FDA) approval as a treatment for various hematological malignancies, demonstrating promising preclinical efficacy against cancers. However, the intricate and resource-intensi...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
KeAi Communications Co., Ltd.
2024-12-01
|
| 叢編: | Bioactive Materials |
| 主題: | |
| 在線閱讀: | http://www.sciencedirect.com/science/article/pii/S2452199X24003840 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|